PMC:7594251 / 16450-16728
Annnotations
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T67710 | 211-212 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T125 | 108-112 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T126 | 244-246 | Chemical | denotes | 1H | http://purl.obolibrary.org/obo/CHEBI_49637 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
173 | 101-104 | Chemical | denotes | 13C | MESH:C000615229 |
174 | 244-246 | Chemical | denotes | 1H | |
175 | 251-254 | Chemical | denotes | 13C | MESH:C000615229 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T116 | 87-170 | Sentence | denotes | The use of 1D 13C in drug design studies was illustrated by Tsujimoto et al. [112]. |